In 2025, more than seven million Americans aged 65 and up were living with Alzheimer’s disease, accounting for roughly one in every nine people in that demographic, according to the Alzheimer’s Association. Alzheimer’s disease is expected to remain the sixth biggest cause of mortality in 2023, according to research. Alzheimer’s disease is the most common form of dementia, affecting those over the age of 60. It impairs memory and thinking abilities, impacting our general capacity to complete simple brain-based tasks. As a result, a team of researchers from UTHealth Houston discovered that those who received a high-dose influenza vaccine had a nearly 55% lower chance of developing Alzheimer’s disease, compared to the 40% reduction previously associated with the standard-dose vaccine.
In 2022, a team led by Dr. Paul Schulz, a neurology professor at McGovern Medical School at UTHealth Houston and director of the Neurocognitive Disorders Center at UTHealth Houston Neurosciences, found that adults 65 and older who got a flu vaccine had a lower risk of Alzheimer’s disease. Later work from the group put that reduction at about 40%. That raised a new question: Does the strength of the shot matter? The question is practical. After age 65, the immune system becomes less effective at fighting infection, so the Centers for Disease Control and Prevention (CDC) recommends a high-dose flu vaccine that contains four times the standard amount of antigen. Antigens are the parts of a vaccine that train the immune system to recognize a virus. But the senior population is growing, and in some areas it outnumbers the supply of high-dose shots, so some older adults get the standard dose instead.
That gave the researchers a natural comparison. They analyzed health records from nearly 200,000 adults 65 and older. The study was published in the journal Neurology. Adults who received the high-dose vaccine had an almost 55% lower risk of Alzheimer’s than unvaccinated adults, compared with about 40% for the standard dose. The protection also appeared stronger in women. There are limits to what this shows. The researchers looked back at existing medical records instead of following two controlled groups over time, which can introduce bias or missing information. The study shows a link, not a cause: People who choose the high-dose shot may also have healthier habits or see their doctors more often. It also only included people over 65, so it can’t say whether the same benefit applies to younger adults.
Overall, the evidence points in a consistent direction: Flu vaccination in older adults is associated with a lower risk of Alzheimer’s, and a stronger dose appears to be associated with an even lower risk. As it prevents severe flu infections, it reduces inflammation in the body, which may indirectly protect the brain. It strengthens the case for something that has previously been recommended: Older folks should have their flu shots every year, and the CDC recommends the high-dose version for people 65 and older.
